MIR4318

Across TCGA pan-cancer cohorts, MIR4318 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR4318 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR4318 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4318 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

KIRC, BRCA, and LAML are the cancer types where MIR4318 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.160	0.624	.003	54	view →
BRCA	OS	Tertile	All	0.336	0.924	.010	54	view →
LAML	DFS	Tertile	All	0.055	0.576	<.001	54	view →
HNSC	DFS	Tertile	IV	1.000	0.337	.012	48	view →
STAD	DFS	Tertile	II,III,IV	0.072	0.697	<.001	45	view →
UCEC	DFS	Tertile	All	0.100	0.646	.024	36	view →
LGG	DFS	Tertile	All	0.083	0.826	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR4318–KIRC (DFS)

Open the KIRC breakdown →